Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Gunderson Thomas James. Officer active across 2 companies, notably Merit Medical Systems INC. Cumulatively, 10 disclosures have been published. History available since 17 June 2021. The latest transaction was disclosed on 22 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
Gunderson Thomas James is a director at Merit Medical Systems INC and at TransMedics Group, Inc. He has 10 filings in total, and across the 10 most recent filings covered, the modal transaction nature is Attribution, with a period from 2021-06-21 to 2025-05-23; both buy and sell amounts are 0.